1. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women 
Alessandro D Genazzani, M.D., Ph.D., Massimo Stomati, M.D., Claudia Strucchi, M.D., Simone Puccetti, M.D., Stefano Luisi, M.D., Andrea R Genazzani, M.D. 
Fertility and Sterility 
Volume 76, Issue 2, Pages (August 2001)
DOI: /S (01)

2. Figure 1
Growth hormone response to the GHRH stimulation test in the four groups of women under study. (A), Lean postmenopausal women, aged 50 to 55 years. (B), Lean postmenopausal women, aged 60 to 65 years. (C), Overweight postmenopausal women, aged 50 to 55 years. (D), Overweight postmenopausal women, aged 60 to 65 years. Profiles of GH response appear relatively modified by the DHEA administration. ■ Before treatment; ▴ Sixth month of treatment.
Genazzani. DHEA administration modulates the GHRH-GH-IGF-J axis. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01) )

3. Figure 2
GH response to GH-RH expressed as mean Δ in Group A (lean postmenopausal women), Group B (obese postmenopausal women), Group C (lean, late postmenopausal women), and Group D (obese, late postmenopausal women). (A), Baseline. (B), Mean percent variation. (C), Mean maximum GH response. The different way of representing the response of GH might condition data interpretation even if it appears clear that aging and obesity induce a lower response of GH to GHRH (panels A to B). The dotted bar is before treatment; the stripped bar is the sixth month of treatment. ∗∗P <.01 vs. all groups; ∗P <.05 vs. before treatment
Genazzani. DHEA administration modulates the GHRH-GH-IGF-I axis. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01) )

4. Figure 3
IGF-1 response to the GHRH stimulation test in the four groups of women under study. (A), Lean postmenopausal women, aged 50 to 55 years. (B), Lean postmenopausal women, aged 60 to 65 years. (C), Overweight postmenopausal women, aged 50 to 55 years. (D), Overweight postmenopausal women, aged 60 to 65 years. The profiles of IGF-1 response appear to be scarcely modified by the DHEA administration. ■ Before treatment; ▴ sixth month of treatment.
Genazzani. DHEA administration modulates the GHRH-GH-IGF-I axis. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01) )

5. Figure 4
IGF-1 response to GHRH expressed as (A), mean Δ from baseline values, (B), mean percentage variation, or (C), mean maximum GH response in the early postmenopausal lean (Group A) and obese (Group B) and late postmenopausal lean (Group C) and obese (Group D) women. The different way of representing the response of IGF-1 might condition data interpretation. Only obese early postmenopausal women showed a significant IGF-1 Δ (A). DHEA administration influenced IGF-1 response to GH-RH increasing IGF-1 plasma levels more than the entity of the response, because the IGF-1 response minimally changed (A–B). Maximum IGF-1 responses were obviously increased (C). Dotted bar is before treatment; stripped bar is sixth month of treatment. ∗P <.05 or ∗∗P <.01 vs. before treatment.
Genazzani. DHEA administration modulates the GHRH-GH-IGF-I axis. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01) )